Search the web
Sign In
New User? Sign Up
nathanfaustmantrials · JoinLeeNow Nathan/Faustman Trials Group
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Real people. Real stories. See how Yahoo! Groups impacts members worldwide.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
other options? Novartis Gleevec and Pfizer Sutent   Message List  
Reply | Forward Message #560 of 634 |
Re: [nathanfaustmantrials] other options? Novartis Gleevec and Pfizer Sutent


My experience has been that every year about 4 different type-1 diabetes cures are found in mice.  This sounds like one of them.  My experience is that less than half of these cures are ever even tried in people.  I wait until someone is trying to organize a human trial before I start to track possible cures.

To see my list of type-1 cures currently in human trials, or with human trials planned, look here: http://joshualevy.pbwiki.com/DiabetesCureReadyForHumanTrials
Although the research you ask about will not be there, because it is mice only.

I would be especially careful about cancer drugs repurposed for type-1 diabetes.  Many cancer drugs are quite toxic, but this is a small price to pay to cure or even slow down your leukemia.  However, it might be too high a price to pay compared with standard type-1 diabetes treatments (even if they are not cures).

Joshua Levy

--- On Tue, 11/18/08, Razvan Lefter <r_lefter@...> wrote:
From: Razvan Lefter <r_lefter@...>
Subject: [nathanfaustmantrials] other options? Novartis Gleevec and Pfizer Sutent
To: nathanfaustmantrials@yahoogroups.com
Date: Tuesday, November 18, 2008, 7:25 AM

Just announced this morning, does anyone have any other input on this?
 
Kind regards, R
 
    NOVARTIS <NOVN.VX>
    Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from
developing type 1 diabetes and put 80 percent of diabetic mice in remission, an
international team said.
    Both drugs -- Gleevec, or imatinib, made by Novartis AG <NOVN.VX> and
Sutent, or sunitinib, made by Pfizer Inc <PFE.N> -- worked by depressing the
immune systems in the mice, which maintained normal blood sugar levels even
after treatment ended.


Razvan Lefter
Mobile: + 40 752 064 000 (new!!!)
E-mail: razvan.lefter@ gmail.com




Tue Nov 18, 2008 7:38 pm

joshua2levy
Online Now Online Now
Send Email Send Email

Forward
Message #560 of 634 |
Expand Messages Author Sort by Date

Just announced this morning, does anyone have any other input on this? Kind regards, R NOVARTIS <NOVN.VX> Two popular leukemia drugs, Gleevec and Sutent, kept...
Razvan Lefter
r_lefter
Offline Send Email
Nov 18, 2008
6:22 pm

My experience has been that every year about 4 different type-1 diabetes cures are found in mice.  This sounds like one of them.  My experience is that less...
Joshua Levy
joshua2levy
Online Now Send Email
Nov 21, 2008
5:21 pm

Hi Everyone, I know this has been awhile in the making, but the website is live and fully functional! http://www.CureType1DiabetesNow.org Our mission now is...
wjperritt
Offline Send Email
Nov 26, 2008
7:12 pm

Bill Thanks for your extraordinary efforts. I will start sending theURL and message to those on my e-mail list. Thanks Again Charlie "Even if you are on the...
ChasMiller
CEMillerIII
Offline Send Email
Nov 28, 2008
10:42 pm

I think the important part of this is that it depressed the immune system.. Which sounds nonselective. While an important discovery, to maintain quality of...
ivan roseland
iroseland
Offline Send Email
Nov 21, 2008
5:21 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help